Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 789 

    Article Cited by others

ORIGINAL ARTICLE

Virologic response and safety of tenofovir versus entecavir in treatment-naïve chronic Hepatitis B patients

Yu Hyung Min, Kwon So Young, Kim Jiwan, Chung Hyun Ah, Kwon Se Woong, Jeong Taek Gun, An Sang Hee, Jeong Gyung Won, Yun Seon Ung, Min Jae Ki, Kim Jeong Han, Choe Won Hyeok

Year : 2015| Volume: 21| Issue : 3 | Page no: 146-151

   This article has been cited by
 
1 Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis B
Chantelli Iamblaudiot Razafindrazoto, Tovo Harimanana Rabenjanahary, Andry Lalaina Rinà Rakotozafindrabe, Sedera Radoniaina Rakotondrasoa, Nitah Harivony Randriamifidy, Anjaramalala Sitraka Rasolonjatovo, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy, Haruki Komatsu
BioMed Research International. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
2 Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis
Xuefeng Ma, Shousheng Liu, Mengke Wang, Yifen Wang, Shuixian Du, Yongning Xin, Shiying Xuan
Journal of Clinical and Translational Hepatology. 2021; 000(000): 000
[Pubmed]  [Google Scholar] [DOI]
3 Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis
Ingyoon Ha, Jung Wha Chung, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim
Journal of Gastroenterology and Hepatology. 2020; 35(10): 1774
[Pubmed]  [Google Scholar] [DOI]

 

Read this article